Efficacy of Mindfulness-Based Relapse Prevention

基于正念的复发预防的功效

基本信息

  • 批准号:
    7268048
  • 负责人:
  • 金额:
    $ 18.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-15 至 2009-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The broad, long-term objective of the current research is to improve treatment for alcohol and other drug (AOD) use disorders through development of an innovative alternative approach to preventing AOD relapse. The specific aims of the research are 1) To develop a manual and therapist adherence/competence measures to standardize delivery of a Mindfulness-Based Relapse Prevention (MBRP) program for post-treatment relapse prevention of AOD problems, which will be patterned after Mindfulness-Based Cognitive Therapy for Depression (Segal, Teasdale & Williams, 2002) and incorporate cognitive-behavioral relapse prevention strategies (Daley & Marlatt, 1997); 2) To conduct a pilot randomized clinical trial to assess the feasibility of recruiting and retaining individuals for a large scale study and to determine effect size of MBRP in comparison to cognitive-behavioral group relapse prevention based on Marlatt's Relapse Prevention model (RP) alone (Daley & Marlatt, 1997). Both MBRP and RP conditions will be compared to a treatment as usual control group (TAU) in a sample of participants enrolled in continuing care following Intensive Outpatient Treatment, at baseline, post-treatment, 2-, and 4-months following the baseline assessment; and 3) Evaluate potential mediators of MBRP and RP treatment efficacy. We hypothesize that both MBRP and RP will be more efficacious than TAU. We hypothesize MBRP efficacy will be mediated by meta-cognitive processes, thought suppression, locus of control, skills to cope with urges and cravings, negative affect and meditation practice. We hypothesize RP efficacy will be mediated by self-efficacy, negative affect and coping abilities. This research builds on over 25 years of developing and implementing RP interventions. MBRP incorporates specific alcohol and drug-focused cognitive therapy techniques with an additional emphasis on mindfulness skills, and builds upon the Investigator's prior work on meditation-based interventions.
描述(由申请人提供): 当前研究的广泛、长期目标是通过开发一种预防AOD复发的创新替代方法来改善对酒精和其他药物使用障碍的治疗。这项研究的具体目标是:1)制定手册和治疗师的依从性/能力措施,以规范AOD问题治疗后复发预防的基于正念的复发预防(MBRP)计划的实施,该计划将仿效基于正念的抑郁症认知疗法(西格尔,泰斯代尔和威廉姆斯,2002),并纳入认知-行为复发预防策略(Daley&Marlatt,1997);2)进行一项试验性随机临床试验,以评估在大规模研究中招募和保留个体的可行性,并确定MBRP与仅基于Marlatt的复发预防模型(RP)的认知-行为群体复发预防的效果大小(Daley&Marlatt,1997)。将在基线、治疗后、基线评估后的2个月和4个月时,将MBRP和RP的情况与常规治疗对照组(TAU)进行比较;以及3)评估MBRP和RP治疗有效性的潜在中介因素。我们假设MBRP和RP都比TAU更有效。我们假设MBRP的有效性将通过元认知过程、思维抑制、控制点、应对冲动和渴望的技能、负面情绪和冥想练习来调节。我们假设RP效应将通过自我效能感、负面情绪和应对能力来调节。这项研究建立在超过25年的RP干预开发和实施的基础上。MBRP结合了特定的以酒精和药物为重点的认知治疗技术,并特别强调正念技能,并建立在研究者先前关于冥想干预的工作基础上。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mindfulness-based relapse prevention for substance craving.
  • DOI:
    10.1016/j.addbeh.2012.04.001
  • 发表时间:
    2013-02
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Witkiewitz, Katie;Bowen, Sarah;Douglas, Haley;Hsu, Sharon H.
  • 通讯作者:
    Hsu, Sharon H.
Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.
  • DOI:
    10.1001/jamapsychiatry.2013.4546
  • 发表时间:
    2014-05
  • 期刊:
  • 影响因子:
    25.8
  • 作者:
    Bowen, Sarah;Witkiewitz, Katie;Clifasefi, Seema L.;Grow, Joel;Chawla, Neharika;Hsu, Sharon H.;Carroll, Haley A.;Harrop, Erin;Collins, Susan E.;Lustyk, M. Kathleen;Larimer, Mary E.
  • 通讯作者:
    Larimer, Mary E.
Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention.
Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.
  • DOI:
    10.1080/08897070903250084
  • 发表时间:
    2009-10
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Bowen S;Chawla N;Collins SE;Witkiewitz K;Hsu S;Grow J;Clifasefi S;Garner M;Douglass A;Larimer ME;Marlatt A
  • 通讯作者:
    Marlatt A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gordon ALAN Marlatt其他文献

Gordon ALAN Marlatt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gordon ALAN Marlatt', 18)}}的其他基金

Mindfulness-Based Relapse Prevention: Efficacy and Mechanisms
基于正念的复发预防:功效和机制
  • 批准号:
    7737899
  • 财政年份:
    2009
  • 资助金额:
    $ 18.4万
  • 项目类别:
Efficacy of Mindfulness-Based Relapse Prevention
基于正念的复发预防的功效
  • 批准号:
    7033623
  • 财政年份:
    2006
  • 资助金额:
    $ 18.4万
  • 项目类别:
Innovative Approaches to Modeling Alcohol Relapse
酒精复吸建模的创新方法
  • 批准号:
    6744174
  • 财政年份:
    2003
  • 资助金额:
    $ 18.4万
  • 项目类别:
Innovative Approaches to Modeling Alcohol Relapse
酒精复吸建模的创新方法
  • 批准号:
    6560580
  • 财政年份:
    2003
  • 资助金额:
    $ 18.4万
  • 项目类别:
Effects of Meditation on Alcohol Use and Recidivism
冥想对饮酒和累犯的影响
  • 批准号:
    6316160
  • 财政年份:
    2000
  • 资助金额:
    $ 18.4万
  • 项目类别:
Effects of Meditation on Alcohol Use and Recidivism
冥想对饮酒和累犯的影响
  • 批准号:
    6371851
  • 财政年份:
    2000
  • 资助金额:
    $ 18.4万
  • 项目类别:
INTERVENTION FOR ADOLESCENT INDIAN DRINKING
印度青少年饮酒干预措施
  • 批准号:
    6168511
  • 财政年份:
    1999
  • 资助金额:
    $ 18.4万
  • 项目类别:
INTERVENTION FOR ADOLESCENT INDIAN DRINKING
印度青少年饮酒干预措施
  • 批准号:
    2885982
  • 财政年份:
    1999
  • 资助金额:
    $ 18.4万
  • 项目类别:
INTERVENTION FOR ADOLESCENT INDIAN DRINKING
印度青少年饮酒干预措施
  • 批准号:
    6371570
  • 财政年份:
    1999
  • 资助金额:
    $ 18.4万
  • 项目类别:
PREVENTION OF ALCOHOL PROBLEMS IN THE UNIVERSITY SETTING
大学环境中酒精问题的预防
  • 批准号:
    3075272
  • 财政年份:
    1987
  • 资助金额:
    $ 18.4万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了